Clinical trial · Interventional
A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework
Occupational Resilience: A Pilot Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
* Aim 1: To determine the preliminary effect sizes of al ActiveHeal EST (Engage-Sustain-Triumph) Program on occupational resilience. * Aim 2: To determine the preliminary effect sizes of ActiveHeal EST (Engage-Sustain-Triumph) on health status \[quality of life (QoL) and Psychological wellbeing (PWB)\]. * Aim 3: To determine the extent to which ActiveHeal EST (Engage-Sustain-Triumph) Program is an acceptable and feasible Intervention for breast and prostate cancer survivors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ActiveHeal | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Group A will receive telehealth occupational therapy services for 12 weeks
- interventionNames
- Behavioral: ActiveHeal
- type
- NO_INTERVENTION
- label
- Control
- description
- Group B will meet three times via zoom but not receive an intervention
Primary outcomes (1)
- measure
- Occupational Resilience Measure (ORM 1.0)
- timeFrame
- Week 7-8; Week 22-23
- description
- The ability to persist in selected daily activity despite challenges
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria * Must be an adult, diagnosed within the last 12 months with prostate or breast cancer and have had treatment(s) that may be ongoing or completed. * Must be 18-75 years old. * Must score 80 to 90 on the Karnofsky Performance Status Scale (KPSS) Exclusion Criteria * Unable to use or lacking access to Teams (internet) and telephone during the study period. * Unable or unwilling to participate in activity-based interventions.
References
Publications (0)
Data not yet available